Musclin prevents depression-like behavior in male mice by activating urocortin 2 signaling in the hypothalamus

IntroductionPhysical activity is recommended as an alternative treatment for depression. Myokines, which are secreted from skeletal muscles during physical activity, play an important role in the skeletal muscle-brain axis. Musclin, a newly discovered myokine, exerts physical endurance, however, the...

Full description

Bibliographic Details
Main Authors: Koji Ataka, Akihiro Asakawa, Haruki Iwai, Ikuo Kato
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-12-01
Series:Frontiers in Endocrinology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fendo.2023.1288282/full
_version_ 1797404511932776448
author Koji Ataka
Koji Ataka
Akihiro Asakawa
Haruki Iwai
Ikuo Kato
author_facet Koji Ataka
Koji Ataka
Akihiro Asakawa
Haruki Iwai
Ikuo Kato
author_sort Koji Ataka
collection DOAJ
description IntroductionPhysical activity is recommended as an alternative treatment for depression. Myokines, which are secreted from skeletal muscles during physical activity, play an important role in the skeletal muscle-brain axis. Musclin, a newly discovered myokine, exerts physical endurance, however, the effects of musclin on emotional behaviors, such as depression, have not been evaluated. This study aimed to access the anti-depressive effect of musclin and clarify the connection between depression-like behavior and hypothalamic neuropeptides in mice.MethodsWe measured the immobility time in the forced swim (FS) test, the time spent in open arm in the elevated-plus maze (EPM) test, the mRNA levels of hypothalamic neuropeptides, and enumerated the c-Fos-positive cells in the paraventricular nucleus (PVN), arcuate nucleus (ARC), and nucleus tractus solitarii (NTS) in mice with the intraperitoneal (i.p.) administration of musclin. Next, we evaluated the effects of a selective corticotropin-releasing factor (CRF) type 1 receptor antagonist, selective CRF type 2 receptor antagonist, melanocortin receptor (MCR) agonist, and selective melanocortin 4 receptor (MC4R) agonist on changes in behaviors induced by musclin. Finally we evaluated the antidepressant effect of musclin using mice exposed to repeated water immersion (WI) stress.ResultsWe found that the i.p. and i.c.v. administration of musclin decreased the immobility time and relative time in the open arms (open %) in mice and increased urocortin 2 (Ucn 2) levels but decreased proopiomelanocortin levels in the hypothalamus. The numbers of c-Fos-positive cells were increased in the PVN and NTS but decreased in the ARC of mice with i.p. administration of musclin. The c-Fos-positive cells in the PVN were also found to be Ucn 2-positive. The antidepressant and anxiogenic effects of musclin were blocked by central administration of a CRF type 2 receptor antagonist and a melanocortin 4 receptor agonist, respectively. Peripheral administration of musclin also prevented depression-like behavior and the decrease in levels of hypothalamic Ucn 2 induced by repeated WI stress.DiscussionThese data identify the antidepressant effects of musclin through the activation of central Ucn 2 signaling and suggest that musclin and Ucn 2 can be new therapeutic targets and endogenous peptides mediating the muscle−brain axis.
first_indexed 2024-03-09T02:56:04Z
format Article
id doaj.art-6b66e8e0af6d4a1bad91d48969d91ae8
institution Directory Open Access Journal
issn 1664-2392
language English
last_indexed 2024-03-09T02:56:04Z
publishDate 2023-12-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Endocrinology
spelling doaj.art-6b66e8e0af6d4a1bad91d48969d91ae82023-12-05T04:27:18ZengFrontiers Media S.A.Frontiers in Endocrinology1664-23922023-12-011410.3389/fendo.2023.12882821288282Musclin prevents depression-like behavior in male mice by activating urocortin 2 signaling in the hypothalamusKoji Ataka0Koji Ataka1Akihiro Asakawa2Haruki Iwai3Ikuo Kato4Laboratory of Medical Biochemistry, Kobe Pharmaceutical University, Kobe, JapanDepartment of Psychosomatic Internal Medicine, Kagoshima University Graduate School of Medical and Dental Sciences, Kagoshima, JapanDepartment of Psychosomatic Internal Medicine, Kagoshima University Graduate School of Medical and Dental Sciences, Kagoshima, JapanDepartment of Oral Anatomy and Cell Biology, Kagoshima University Graduate School of Medical and Dental Sciences, Kagoshima, JapanLaboratory of Medical Biochemistry, Kobe Pharmaceutical University, Kobe, JapanIntroductionPhysical activity is recommended as an alternative treatment for depression. Myokines, which are secreted from skeletal muscles during physical activity, play an important role in the skeletal muscle-brain axis. Musclin, a newly discovered myokine, exerts physical endurance, however, the effects of musclin on emotional behaviors, such as depression, have not been evaluated. This study aimed to access the anti-depressive effect of musclin and clarify the connection between depression-like behavior and hypothalamic neuropeptides in mice.MethodsWe measured the immobility time in the forced swim (FS) test, the time spent in open arm in the elevated-plus maze (EPM) test, the mRNA levels of hypothalamic neuropeptides, and enumerated the c-Fos-positive cells in the paraventricular nucleus (PVN), arcuate nucleus (ARC), and nucleus tractus solitarii (NTS) in mice with the intraperitoneal (i.p.) administration of musclin. Next, we evaluated the effects of a selective corticotropin-releasing factor (CRF) type 1 receptor antagonist, selective CRF type 2 receptor antagonist, melanocortin receptor (MCR) agonist, and selective melanocortin 4 receptor (MC4R) agonist on changes in behaviors induced by musclin. Finally we evaluated the antidepressant effect of musclin using mice exposed to repeated water immersion (WI) stress.ResultsWe found that the i.p. and i.c.v. administration of musclin decreased the immobility time and relative time in the open arms (open %) in mice and increased urocortin 2 (Ucn 2) levels but decreased proopiomelanocortin levels in the hypothalamus. The numbers of c-Fos-positive cells were increased in the PVN and NTS but decreased in the ARC of mice with i.p. administration of musclin. The c-Fos-positive cells in the PVN were also found to be Ucn 2-positive. The antidepressant and anxiogenic effects of musclin were blocked by central administration of a CRF type 2 receptor antagonist and a melanocortin 4 receptor agonist, respectively. Peripheral administration of musclin also prevented depression-like behavior and the decrease in levels of hypothalamic Ucn 2 induced by repeated WI stress.DiscussionThese data identify the antidepressant effects of musclin through the activation of central Ucn 2 signaling and suggest that musclin and Ucn 2 can be new therapeutic targets and endogenous peptides mediating the muscle−brain axis.https://www.frontiersin.org/articles/10.3389/fendo.2023.1288282/fullmusclindepressionurocortin 2muscle-brain axismyokines
spellingShingle Koji Ataka
Koji Ataka
Akihiro Asakawa
Haruki Iwai
Ikuo Kato
Musclin prevents depression-like behavior in male mice by activating urocortin 2 signaling in the hypothalamus
Frontiers in Endocrinology
musclin
depression
urocortin 2
muscle-brain axis
myokines
title Musclin prevents depression-like behavior in male mice by activating urocortin 2 signaling in the hypothalamus
title_full Musclin prevents depression-like behavior in male mice by activating urocortin 2 signaling in the hypothalamus
title_fullStr Musclin prevents depression-like behavior in male mice by activating urocortin 2 signaling in the hypothalamus
title_full_unstemmed Musclin prevents depression-like behavior in male mice by activating urocortin 2 signaling in the hypothalamus
title_short Musclin prevents depression-like behavior in male mice by activating urocortin 2 signaling in the hypothalamus
title_sort musclin prevents depression like behavior in male mice by activating urocortin 2 signaling in the hypothalamus
topic musclin
depression
urocortin 2
muscle-brain axis
myokines
url https://www.frontiersin.org/articles/10.3389/fendo.2023.1288282/full
work_keys_str_mv AT kojiataka musclinpreventsdepressionlikebehaviorinmalemicebyactivatingurocortin2signalinginthehypothalamus
AT kojiataka musclinpreventsdepressionlikebehaviorinmalemicebyactivatingurocortin2signalinginthehypothalamus
AT akihiroasakawa musclinpreventsdepressionlikebehaviorinmalemicebyactivatingurocortin2signalinginthehypothalamus
AT harukiiwai musclinpreventsdepressionlikebehaviorinmalemicebyactivatingurocortin2signalinginthehypothalamus
AT ikuokato musclinpreventsdepressionlikebehaviorinmalemicebyactivatingurocortin2signalinginthehypothalamus